Response of risperidone treatment may be associated with polymorphisms of HTT gene in chinese schizophrenia patientsLEI WANG; LAN YU; YUE XIAO et al.Neuroscience letters. 2007, Vol 414, Num 1, pp 1-4, issn 0304-3940, 4 p.Article

Impact clinique des neuroleptiques atypiques : étude prospective sur 6 mois en milieu hospitalier de patients traités par rispéridone ou olanzapine = Clinical impact of atypical antipsychotics: prospective 6-month study of inpatients treated by risperidone or olanzapineHAMEL, B; COURTET, P; VERGNES, C et al.Thérapie (Paris). 2001, Vol 56, Num 6, pp 645-652, issn 0040-5957, 8 p.Article

Clinical review of a long-acting, injectable formulation of risperidoneKNOX, Erin Danielle; STIMMEL, Glen L.Clinical therapeutics. 2004, Vol 26, Num 12, pp 1994-2002, issn 0149-2918, 9 p.Article

QTc interval, CYP2D6 and CYP2C9 genotypes and risperidone plasma concentrationsLIERENA, Adrian; BERECZ, Roland; DORADO, Pedro et al.Journal of psychopharmacology (Oxford). 2004, Vol 18, Num 2, pp 189-193, issn 0269-8811, 5 p.Article

Risperidone prolongs cardiac repolarization by blocking the rapid component of the delayed rectifier potassium currentDROLET, Benoit; YANG, Tao; DALEAU, Pascal et al.Journal of cardiovascular pharmacology. 2003, Vol 41, Num 6, pp 934-937, issn 0160-2446, 4 p.Article

Resolution of risperidone-induced hyperprolactinemia with substitution of quetiapineARUN RAJ KUNWAR; MEGNA, James L.The Annals of pharmacotherapy. 2003, Vol 37, Num 2, pp 206-208, issn 1060-0280, 3 p.Article

Risperidone for control of agitation in dementia patientsFALSETTI, A. E.American journal of health-system pharmacy. 2000, Vol 57, Num 9, pp 862-870, issn 1079-2082Article

Switching from therapy with typical antipsychotic agents to risperidone : Long-term impact on patient outcomeMALLA, A. K; NORMAN, R. M. G; KOTTEDA, V et al.Clinical therapeutics. 1999, Vol 21, Num 5, pp 806-817, issn 0149-2918Article

Risperidone-induced photosensitivityALMOND, D. S; RHODES, L. E; PIRMOHAMED, M et al.Postgraduate medical journal. 1998, Vol 74, Num 870, pp 252-253, issn 0032-5473Article

Syndrome malin des neuroleptiques induit par la rispéridone = Risperidone-induced neuroleptic malignant syndromeROHRBACH, P; COLLINOT, J. P; VALLET, G et al.Annales françaises d'anesthésie et de réanimation. 1998, Vol 17, Num 1, pp 85-86, issn 0750-7658Article

Clinical experience with the long-acting injectable formulation of the atypical antipsychotic, risperidoneMARTIN, Stephen D; LIBRETTO, Susan E; PRATT, David J et al.Current medical research and opinion. 2003, Vol 19, Num 4, pp 298-305, issn 0300-7995, 8 p.Article

Clinical trial response and dropout rates with olanzapine versus risperidoneSANTARLASCI, Benedetta; MESSORI, Andrea.The Annals of pharmacotherapy. 2003, Vol 37, Num 4, pp 556-563, issn 1060-0280, 8 p.Article

Risperidone and Total 9-Hydroxyrisperidone in Relation to Prescribed Dose and Other Factors: Data From a Therapeutic Drug Monitoring Service, 2002-2010BOWSKILL, Sally V. J; HANDLEY, Simon A; FISHER, Danielle S et al.Therapeutic drug monitoring. 2012, Vol 34, Num 3, pp 349-355, issn 0163-4356, 7 p.Article

Association between a polymorphism of the HTR3A gene and therapeutic response to risperidone treatment in drug-naive Chinese schizophrenia patientsBO GU; LEI WANG; ZHANG, Ai-Ping et al.Pharmacogenetics and genomics (Print). 2008, Vol 18, Num 8, pp 721-727, issn 1744-6872, 7 p.Article

An open-label extension trial of risperidone monotherapy in the treatment of bipolar I disorderHIRSCHFELD, Robert M. A; EERDEKENS, Mariëlle; KALALI, Amir H et al.International clinical psychopharmacology. 2006, Vol 21, Num 1, pp 11-20, issn 0268-1315, 10 p.Article

Risperidone treatment of bipolar maniaNGUYEN, Lisa N; GUTHRIE, Sally K.The Annals of pharmacotherapy. 2006, Vol 40, Num 4, pp 674-682, issn 1060-0280, 9 p.Article

Serum ghrelin concentrations in patients receiving olanzapine or risperidoneTOGO, Takashi; HASEGAWA, Koichi; MIURA, Satoshi et al.Psychopharmacologia. 2004, Vol 172, Num 2, pp 230-232, issn 0033-3158, 3 p.Article

Low doses of risperidone and morphine interact to produce more analgesia and greater extrapyramidal effects in ratsDIPIRRO, Jean M; THOMPSON, Alexis C; SUAREZ, Mauricio et al.Neuroscience letters. 2011, Vol 490, Num 1, pp 21-26, issn 0304-3940, 6 p.Article

Long-acting risperidone : Focus on safetyMÖLLER, Hans-Jürgen.Clinical therapeutics. 2006, Vol 28, Num 5, pp 633-651, issn 0149-2918, 19 p.Article

Establishing a dose-response relationship for oral risperidone in relapsed schizophreniaEZEWUZIE, Niina; TAYLOR, David.Journal of psychopharmacology (Oxford). 2006, Vol 20, Num 1, pp 86-90, issn 0269-8811, 5 p.Article

Impact of haloperidol and risperidone on gene expression profile in the rat cortexFEHER, Liliana Z; KALMAN, Janos; MATIN, Keyvan et al.Neurochemistry international. 2005, Vol 47, Num 4, pp 271-280, issn 0197-0186, 10 p.Article

Sensitive chemiluminescence assay for risperidone in pharmaceutical preparationsZHENGHUA SONG; CHANGNA WANG.Journal of pharmaceutical and biomedical analysis. 2004, Vol 36, Num 3, pp 491-494, issn 0731-7085, 4 p.Article

Serum adiponectin concentrations during treatment with olanzapine or risperidone: a pilot studyTOGO, Takashi; KOJIMA, Katsuo; SHOJI, Mika et al.International clinical psychopharmacology. 2004, Vol 19, Num 1, pp 37-40, issn 0268-1315, 4 p.Article

Effets respiratoires de la rispéridone ? Étude prospective = Respiratory effects of risperidone? A prospective studyTOURAINE, F; ANTONINI, M.-T; BOURLOT, D et al.Revue de pneumologie clinique (Paris). 2003, Vol 59, Num 1, pp 33-37, issn 0761-8417, 5 p.Article

Mood stabilization and the role of antipsychoticsYATHAM, Lakshmi N.International clinical psychopharmacology. 2002, Vol 17, pp S21-S27, issn 0268-1315, SUP3Conference Paper